Home | Welcome to Contract Pharma   
Last Updated Tuesday, October 21 2014
Print

WuXi PharmaTech Completes St. Paul Facility Expansion



Published May 12, 2014
Related Searches: Testing
WuXi PharmaTech, Inc. has completed the expansion of its materials characterization testing facility in St. Paul, MN. The new lab will begin operations by the end of June. 
 
The new 20,000-sq.-ft. lab will offer expanded capacity for existing services, such as particle identification and extractable/leachable testing, and its new service, dynamic light scattering for nanoparticle characterization. The expansion is designed to allow rapid scale-up of technologies to increase capacities for chemical analysis of medical materials.  
 
"WuXi is committed to helping medical device and biologics companies bring their products to market faster," said Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech. "This facility and WuXi's trained staff will better serve our customers' growing need to quantify the chemical safety of materials used in medical devices and biologics."


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On